Shock Reduction Using Absolute Calibrated Tissue Oxygen Saturation and Total Hemoglobin Volume Fraction
First Claim
1. A method, comprising:
- sensing cardiac depolarization signals;
detecting an arrhythmia in response to the depolarization signals;
controlling an optical sensor to emit light in response to the detected arrhythmia;
detecting light scattered by a volume of blood perfused tissue wherein detecting light comprises measuring an optical sensor output signal corresponding to light attenuation of at least four spaced apart light wavelengths;
computing a measure of tissue oxygenation from the optical sensor output signal; and
detecting a hemodynamic status of the arrhythmia in response to the measure of tissue oxygenation.
1 Assignment
0 Petitions
Accused Products
Abstract
An implantable medical device for detecting and treating an arrhythmia includes an optical sensor adapted for positioning adjacent to a blood-perfused tissue volume. In one embodiment for controlling arrhythmia therapies delivered by the device, the optical sensor is controlled to emit light in response to detecting an arrhythmia, detect light scattered by the volume of blood perfused tissue including measuring an optical sensor output signal corresponding to the intensity of scattered light for at least four spaced-apart wavelengths, and compute a volume-independent measure of tissue oxygen saturation from the detected light. The hemodynamic status of the arrhythmia is detected in response to the measure of tissue oxygen saturation.
105 Citations
23 Claims
-
1. A method, comprising:
-
sensing cardiac depolarization signals; detecting an arrhythmia in response to the depolarization signals; controlling an optical sensor to emit light in response to the detected arrhythmia; detecting light scattered by a volume of blood perfused tissue wherein detecting light comprises measuring an optical sensor output signal corresponding to light attenuation of at least four spaced apart light wavelengths; computing a measure of tissue oxygenation from the optical sensor output signal; and detecting a hemodynamic status of the arrhythmia in response to the measure of tissue oxygenation. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
-
12. An implantable medical device, comprising:
-
a cardiac electrode for sensing cardiac depolarization signals; an optical sensor for providing a signal corresponding to light attenuation by a volume of blood perfused tissue; a control module coupled to the optical sensor controlling the light emitted by the optical sensor; a monitoring module receiving an optical sensor output signal and measuring light attenuation for at least four spaced-apart light wavelengths; and a processor coupled to the cardiac electrode and the monitoring module, the processor being configured to detect an arrhythmia in response to the depolarization signals and compute a tissue oxygenation measurement in response to detecting the arrhythmia, the processor further configured to detect a hemodynamic status of the arrhythmia in response to the measure of tissue oxygenation. - View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
-
-
23. A computer readable medium having computer executable instructions for performing a method comprising:
-
sensing cardiac depolarization signals; detecting an arrhythmia in response to the depolarization signals; controlling an optical sensor to emit light in response to the detected arrhythmia; detecting light scattered by a volume of blood perfused tissue wherein detecting light comprises measuring an optical sensor output signal corresponding to light attenuation of at least four spaced apart light wavelengths; computing a measure of tissue oxygenation from the optical sensor output signal; and detecting a hemodynamic status of the arrhythmia in response to the measure of tissue oxygenation.
-
Specification